0%
Daily Market Update
02-Mar-20261 min readvipin kumar

Oil jumps as Iran conflict escalates, disrupts shipping- Daily Market Update 2nd March 2026

Get a Smart Summary Instantly

Prompt copied

Oil prices jumped 7% to their highest levels in months on Monday as Iran and Israel stepped up attacks in the Middle East, damaging tankers and disrupting shipments from the key producing region.

Overview and Outlook

Global Stock Market Today

  • US equity markets ended lower in range 0.4% to 1%.
  • European equity markets,barring FTSE, settled on a negative note.
  • Asian equity markets are trading in red.
  • GIFT Nifty is trading down by 120 points, Nifty futures likely to open around 25160 levels.

 

News highlights from across the globe

  • US stock futures tumbled sharply as Sunday evening trading opened on Wall Street, with the Iran–US conflict escalating into a wider Middle East war and igniting another spike in oil prices.
  • Asian equities are trading lower Global markets turned volatile as escalating conflict in the Middle East triggered a broad pullback in risk assets, sending stocks lower and crude oil sharply higher. Investors shifted toward safer havens, lending strength to the US dollar.
  • Oil prices recorded their sharpest jump in four years after escalating US‑Israeli military action against Iran sent shockwaves through global energy markets and effectively shut down the vital Strait of Hormuz. Brent crude spiked nearly 13%, climbing past $82 a barrel — its highest level since January 2025.

 

Important news updates from the domestic front

  • Bharti Airtel plans to invest Rs 20,000 crore over the next few years to capitalise its NBFC arm, Airtel Money.
  • NCC- The Telangana High Court grants an interim suspension of the debarment order previously issued by NHAI.
  • Morepen Labs secures a commercial supply order worth Rs 825 crore under a CDMO arrangement from a global pharma company.
  •  LIC- The corporation commences operations at its new IFSC branch located in GIFT City.
  •  Aurobindo Pharma- The US FDA concludes an inspection at its arm’s Telangana unit (Eugia Pharma Unit-1) with four observations.
  •  Lupin‘s arm is in the process of acquiring a 100% stake in VISUfarma, with completion expected by April.
  •  Canara Bank announces the issuance of Basel III compliant Tier II bonds worth Rs 5,000 crore.
  •  Maruti Suzuki-The NCLAT hearing regarding the company has been adjourned to March 25, 2026.
  •  Bharat Electronics declares an interim dividend of Rs 1.95 per share for the financial year 2025-26.
  •  Lemon Tree Hotels signs a license agreement for a new 55-room hotel in Maharashtra.
  •  Samvardhana Motherson completes the formation of a joint venture with Taiwan-based Macauto Industrial.
  •  Aditya Birla Capital allots 163 Non-Convertible Debentures (NCDs) worth Rs 163 crore.
  •  IRFC– The government completes the sale of a 1.71% stake in the company via the OFS.

 

Nifty Overview & Outlook

The benchmark Nifty index ended sharply lower at 25179 spot levels after shedding 318 points from its previous closing values.

Broader markets fell in line with the benchmark as Mid and Small cap indices were down over 1% each. Majority of sectoral indices, tracked at NSE, were down in range 1% to over 2%.

Domestic markets will initially react to the conflict in Middle East. The broader chart structure remains negative; the underlying weakness makes it difficult for the Nifty index to sustain higher levels. Immediate support is placed around 25000 spot level. A sustained break below the 25000 spot level could drag the index toward 24600, which serves as crucial technical support.

 

Derivatives Overview & Outlook

Last Friday, all index futures moved southward on short buildup as Nifty, Banknifty and Finnifty futures shed around 14.5%, 23% and 4.7% of open interest respectively, whereas no significant change was observed in Midcapnifty futures on open interest front.

All F&O sectors ended on a negative note. Amongst them, Banking, Finance, Metal and Telecom stocks witnessed maximum addition of short positions.

On options front, call writing along with some put addition was seen at multiple OTM strikes. Nifty has maximum positions at 26000 CE followed by 25500 CE, while on the put side, maximum positions are at 25000 PE followed by 24500 PE.

 

Institutional Trading Activity

Last week, FIIs sold stocks worth Rs 1587 Cr in the cash segment, sold index futures worth Rs 5673 Cr and bought stocks futures worth Rs 1846 Cr. DIIs were net sellers in the cash segment to the tune of Rs 24313 Cr during the week.

 

Nifty Futures, Banknifty Futures and Finnifty Futures Key Levels

Nifty – Resistances 25450-25580; Supports 25535-25420

Banknifty – Resistances 61200-61500; Supports 60500-60200

Finnifty – Resistances 28100-28200; Supports 27980- 27900

 

F&O stocks in ban today – SAMMAANCAP

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates. AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited and Lakshya Impex Private Limited are the associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection GC does not take any responsibility thereof. This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months. GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months. Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document. Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Our research analysts may use AI tools to collect, summarize, and present data in order to increase productivity and enhance the clarity and readability of our reports. However, all reports are subject to human review prior to finalization and distribution to end users.

Our published research reports are the property of GCML and its associate and subsidiary companies. These reports may not be copied, reproduced, distributed or otherwise used by any other brokerage or individual firm without the prior written permission of GCML or its associate/subsidiary companies.